Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics Europe Ltd

United Therapeutics Europe clinical programs — 1032 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

United Therapeutics Europe projects

1,032 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.

United Therapeutics Europe has 1,032 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,032 programs

Clinical programs

Page 3 of 22

  1. L-leucovorin

    United Therapeutics Europe Ltd

    Colorectal Cancer

    phase 3 small molecule completed

    1 trial

  2. LY2189265

    United Therapeutics Europe Ltd

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    1 trial

  3. Lactobacillus plantarum

    United Therapeutics Europe Ltd

    Constipation - Functional

    phase 3 small molecule completed

    1 trial

  4. Lactobacillus plantarum IS-10506

    United Therapeutics Europe Ltd

    Constipation - Functional

    phase 3 small molecule completed

    1 trial

  5. Lactose Placebo

    United Therapeutics Europe Ltd

    Elbow Fracture

    phase 3 small molecule completed

    1 trial

  6. MRI

    United Therapeutics Europe Ltd

    Prostate Neoplasm

    phase 3 other completed

    1 trial

  7. Metformin

    United Therapeutics Europe Ltd

    Idiopathic Pulmonary Fibrosis

    phase 3 small molecule active

    1 trial

  8. Metoprolol succinate

    United Therapeutics Europe Ltd

    Pulmonary Disease, Chronic Obstructive

    phase 3 small molecule terminated

    1 trial

  9. Mirasol-treated Fresh Whole Blood

    United Therapeutics Europe Ltd

    Transfusion-Transmitted Infectious Disease

    phase 3 mab completed

    1 trial

  10. Mitomycin-C

    United Therapeutics Europe Ltd

    Corneal Opacity

    phase 3 small molecule active

    1 trial

  11. Moxifloxacin

    United Therapeutics Europe Ltd

    Chronic Obstructive Pulmonary Disease (COPD).

    phase 3 small molecule active

    1 trial

  12. NA_00090926

    United Therapeutics Europe Ltd

    TBI Depression

    phase 3 other completed

    1 trial

  13. New thickened formula

    United Therapeutics Europe Ltd

    Gastroesophageal Reflux

    phase 3 other completed

    1 trial

  14. Niclosamide

    United Therapeutics Europe Ltd

    Covid19

    phase 3 small molecule completed

    1 trial

  15. Nicotinomide

    United Therapeutics Europe Ltd

    Glaucoma, Open-Angle

    phase 3 small molecule active

    1 trial

  16. Nutritional supplements

    United Therapeutics Europe Ltd

    Low Birth Weight

    phase 3 small molecule completed

    1 trial

  17. Obinutuzumab

    United Therapeutics Europe Ltd

    Non-Hodgkin's Lymphoma

    phase 3 small molecule completed

    1 trial

  18. Ondansetron

    United Therapeutics Europe Ltd

    IBS - Irritable Bowel Syndrome

    phase 3 small molecule completed

    1 trial

  19. Oral Treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    phase 3 small molecule completed

    2 trials

  20. Oral Treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Hypertension Associated With Sickle Cell Disease

    phase 3 small molecule terminated

    1 trial

  21. Oral treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 3 small molecule terminated

    2 trials

  22. Oral treprostinil (UT-15C) sustained release tablets

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    phase 3 small molecule completed

    2 trials

  23. Oxandrolone

    United Therapeutics Europe Ltd

    Trauma Injury

    phase 3 small molecule terminated

    1 trial

  24. Oxybutynin Chloride

    United Therapeutics Europe Ltd

    Breast Carcinoma

    phase 3 small molecule completed

    1 trial

  25. PRO 2000/5

    United Therapeutics Europe Ltd

    HIV Infections

    phase 3 small molecule completed

    1 trial

  26. Pembrolizumab 25 MG/ML [Keytruda]

    United Therapeutics Europe Ltd

    Lung Cancer, Nonsmall Cell

    phase 3 small molecule active

    1 trial

  27. Pentoxifylline

    United Therapeutics Europe Ltd

    Kidney Failure, Chronic

    phase 3 small molecule completed

    1 trial

  28. Physiotherapy

    United Therapeutics Europe Ltd

    Sciatica

    phase 3 other completed

    1 trial

  29. Placebo

    United Therapeutics Europe Ltd

    Idiopathic Pulmonary Fibrosis

    phase 3 small molecule completed

    1 trial

  30. Placebo

    United Therapeutics Europe Ltd

    Gulf War Illness

    phase 3 small molecule active

    1 trial

  31. Platelet Rich Plasma Injection

    United Therapeutics Europe Ltd

    Osteoarthritis of the Shoulder

    phase 3 mab completed

    1 trial

  32. Prednisolone

    United Therapeutics Europe Ltd

    Adrenal Insufficiency

    phase 3 small molecule active

    1 trial

  33. Progesterone

    United Therapeutics Europe Ltd

    Alcohol Dependence

    phase 3 small molecule completed

    1 trial

  34. Propranolol

    United Therapeutics Europe Ltd

    Burn

    phase 3 small molecule terminated

    1 trial

  35. RIN-PF-303

    United Therapeutics Europe Ltd

    Idiopathic Pulmonary Fibrosis

    phase 3 small molecule active

    1 trial

  36. RIN-PF-305

    United Therapeutics Europe Ltd

    Progressive Pulmonary Fibrosis

    phase 3 small molecule active

    1 trial

  37. ROR-PH-301

    United Therapeutics Europe Ltd

    Pulmonary arterial hypertension (PAH)

    phase 3 small molecule active

    1 trial

  38. ROR-PH-303

    United Therapeutics Europe Ltd

    Pulmonary arterial hypertension (PAH)

    phase 3 small molecule active

    1 trial

  39. Ralinepag

    United Therapeutics Europe Ltd

    PAH

    phase 3 small molecule terminated

    2 trials

  40. Raltegravir

    United Therapeutics Europe Ltd

    Human Immunodeficiency Virus

    phase 3 small molecule completed

    1 trial

  41. Recombinant Factor VIIa

    United Therapeutics Europe Ltd

    Burns

    phase 3 small molecule completed

    1 trial

  42. Reducing Antibiotics treatment duration

    United Therapeutics Europe Ltd

    Ventilator Associated Pneumonia

    phase 3 small molecule completed

    1 trial

  43. Regorafenib

    United Therapeutics Europe Ltd

    Gastro-Oesophageal Cancer

    phase 3 small molecule active

    1 trial

  44. Remodulin (treprostinil sodium) Injection

    United Therapeutics Europe Ltd

    Peripheral Vascular Disease

    phase 3 small molecule terminated

    1 trial

  45. Remodulin® (treprostinil sodium) Injection

    United Therapeutics Europe Ltd

    Critical Limb Ischemia

    phase 3 small molecule terminated

    1 trial

  46. Revumenib

    United Therapeutics Europe Ltd

    Acute Myeloid Leukemia, Adult

    phase 3 small molecule active

    1 trial

  47. Rifampicin

    United Therapeutics Europe Ltd

    Severe Acute Malnutrition

    phase 3 small molecule active

    1 trial

  48. Riluzole

    United Therapeutics Europe Ltd

    Spinal Cord Injury

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does United Therapeutics Europe have?

1,032 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.